Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease

Basit Öğe Kaydı
dc.contributor.authorİrkeç, Ceyla
dc.contributor.authorTekşut, Tuba Kuz
dc.contributor.authorAdışen, Esra
dc.contributor.authorÖztürk, Banu
dc.contributor.authorFidan, Işıl
dc.contributor.authorGürer, M. Ali
dc.contributor.authorİmir, Turgut
dc.contributor.authorBozkurt, Banu
dc.date.accessioned2020-03-26T18:30:38Z
dc.date.available2020-03-26T18:30:38Z
dc.date.issued2012
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjective: The aim of the present study was to assess the role of CX3CL1 in patients with active and inactive Behcet's Disease (BD), Neuro-Behcet's Disease (NBD) and control subjects. Methods: Fifty-six patients admitted to the BD and NBD Outpatient Clinics, and 30 healthy controls were enrolled in the study. Serum CX3CL1 levels were measured by an enzyme linked immunosorbent assay (ELISA). Results: No significant difference was found between the serum CX3CL1 levels of control subjects, and patients with active and inactive BD or NBD, regardless of treatment. Conclusion: To our knowledge, this is the first study analyzing CX3CL1 levels in patients with BD and NBD. Our results demonstrated that serum CX3CL1 levels were not changed in active and inactive BD and NBD. However, further large-scale studies are needed to confirm our results. (C) 2011 Elsevier B.V. All rights reserved.en_US
dc.identifier.doi10.1016/j.jns.2011.11.011en_US
dc.identifier.endpage122en_US
dc.identifier.issn0022-510Xen_US
dc.identifier.issue01.02.2020en_US
dc.identifier.pmid22177089en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage120en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.jns.2011.11.011
dc.identifier.urihttps://hdl.handle.net/20.500.12395/28074
dc.identifier.volume315en_US
dc.identifier.wosWOS:000302445600025en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherELSEVIER SCIENCE BVen_US
dc.relation.ispartofJOURNAL OF THE NEUROLOGICAL SCIENCESen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectBehcet's diseaseen_US
dc.subjectNeuro-Behcet's diseaseen_US
dc.subjectFractalkine (CX3CL1)en_US
dc.titleFractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's diseaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu